Alam HallanChief Technology Officer at Thor HealthSpeaker
Agenda Sessions
Specialty and Biosimilars — Competing Priorities in a High-Cost Drug Environment
, 11:25amView Session
Specialty and Biosimilars — Competing Priorities in a High-Cost Drug Environment